Antidiabetic effect of iron-rich fortified amla (Emblica officinalis) Ready to Serve (RTS) health drink

Abstract

Many pathological illnesses, including diabetes, have been treated using Emblica officinalis, also known as Amla in Indian Medicine. The main aim of this experimental study is to assess the effects of using Apple Cider Vinegar (ACV) as a preservative in Amla Salt-based Ready to Serve (RTS) beverage in order to preserve blood glucose levels and to investigate the various concentrations of adding ACV to extend the shelf life of the product. The Amla RTS beverages were prepared by adding ACV at four different concentrations (7%, 8%, 9%, and 10%) and subjected to sensory evaluation test at 30 days, 60 days and 180 days interval. At the ICAR-Krishi Vigyan Kendra in Tirunelveli, a study on diabetic Amla ready-to-serve (RTS) beverage was carried out from January to August 2022 with the goals of establishing a standard method of preparation, researching the shelf-life, and assessing the outcomes using sensory evaluation scores. Additionally, evaluation scores for sensory qualities like appearance, colour, flavour, taste, texture, and overall acceptability negligibly decreased from their maximum value, and beverage compositions exhibited no microbial development after six months of storage. It was found that the formulation of Amla RTS beverage prepared with 10% ACV ingredient was more acceptable, safer, and better at maintaining its quality attributes. It will be commercialized as a healthy diet beverage that's suitable for diabetics. This project could increase farmer income by developing a salt-based, ready-to-drink Amla beverage that will help diabetes patients maintain normal blood sugar levels.